Jane Street »

Revance Therapeutics shares owned by Jane Street

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Jane Street from 13F filings

Historical chart of Jane Street investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Jane Street consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Jane Street

Quarter filed Position value Share count Share price at filing
2023-12-31 $503k 57k 8.79
2023-09-30 $1.7M 147k 11.47
2023-06-30 $2.8M 112k 25.31
2023-03-31 $8.9M 275k 32.21
2022-12-31 $472k 26k 18.46
2022-09-30 $6.7M 247k 27.00
2022-06-30 $559k 40k 13.85
2022-03-31 $6.2M 316k 19.48
2021-12-31 $2.4M 150k 16.33
2021-09-30 $1.5M 55k 27.94
2021-06-30 $2.4M 80k 29.64
2021-03-31 $2.8M 100k 27.95
2020-12-31 $2.6M 91k 28.35
2020-09-30 $1.0M 41k 25.17
2019-03-31 $316k 20k 15.78
2018-12-31 $274k 14k 20.16
2017-12-31 $685k 19k 35.73
2015-12-31 $236k 6.9k 34.20